BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17682161)

  • 1. [Prospects for genetic diagnosis].
    Shimoji T; Miki Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():241-4. PubMed ID: 17682161
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hereditary/familial breast cancer].
    Fukutomi T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():245-8. PubMed ID: 17682162
    [No Abstract]   [Full Text] [Related]  

  • 3. [Familial breast cancer genes].
    Chiba N; Ishioka C
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():601-5. PubMed ID: 17682216
    [No Abstract]   [Full Text] [Related]  

  • 4. [Present conditions and the prospects for biomarker measurement in breast cancer].
    Kawamoto H; Fukuda M
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():281-4. PubMed ID: 17679203
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetic alterations and expression changes in breast cancers].
    Terada K; Ushijima T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():113-9. PubMed ID: 17682148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peculiarities of diagnosis, treatment and prevention of hereditary cancer of the breast and ovary. Clinical and genetic screening among BRCA1/2 mutation carriers and individuals with high family risk of cancer].
    Rumiantseva UV; Rumiantsev PO; Kiseleva MV
    Vopr Onkol; 2008; 54(3):251-9. PubMed ID: 18652227
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinicopathological characteristics of familial breast cancer].
    Kamimura M; Takei H; Suemasu K
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():607-9. PubMed ID: 17682217
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on: Sluiter MD and van Rensburg EJ, Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation.
    del Valle J; Feliubadaló L; Lázaro C
    Breast Cancer Res Treat; 2010 Nov; 124(1):295-6. PubMed ID: 20706784
    [No Abstract]   [Full Text] [Related]  

  • 9. Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side.
    Garber JE; Golshan M
    J Clin Oncol; 2009 Dec; 27(35):5862-4. PubMed ID: 19858367
    [No Abstract]   [Full Text] [Related]  

  • 10. BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.
    Palma M; Ristori E; Ricevuto E; Giannini G; Gulino A
    Crit Rev Oncol Hematol; 2006 Jan; 57(1):1-23. PubMed ID: 16337408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of BRCA1 and BRCA2 gene mutations in human sporadic breast cancers].
    Zhang HT; Lu YF; Zeng J; Lin J; Liao QH; Wan FQ
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):480-2. PubMed ID: 17686308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
    Egeli U; Cecener G; Tunca B; Tasdelen I
    Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating the genetic make-up of breast cancer: a new fashion?
    Linn SC; Jonkers J
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1065-7. PubMed ID: 17725409
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in molecular genetics of breast cancer.
    Pavelić K; Gall-Troselj K
    J Mol Med (Berl); 2001 Oct; 79(10):566-73. PubMed ID: 11692153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical management of BRCA1 and BRCA2 mutation carriers.
    Domchek SM; Armstrong K; Weber BL
    Nat Clin Pract Oncol; 2006 Jan; 3(1):2-3. PubMed ID: 16407858
    [No Abstract]   [Full Text] [Related]  

  • 16. BRCA1/2-associated and sporadic breast cancers: fellow travelers or not?
    Garber JE
    Cancer Prev Res (Phila); 2009 Feb; 2(2):100-3. PubMed ID: 19174575
    [No Abstract]   [Full Text] [Related]  

  • 17. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Graeser MK; Engel C; Rhiem K; Gadzicki D; Bick U; Kast K; Froster UG; Schlehe B; Bechtold A; Arnold N; Preisler-Adams S; Nestle-Kraemling C; Zaino M; Loeffler M; Kiechle M; Meindl A; Varga D; Schmutzler RK
    J Clin Oncol; 2009 Dec; 27(35):5887-92. PubMed ID: 19858402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.
    Arnold JM; Choong DY; Thompson ER; ; Waddell N; Lindeman GJ; Visvader JE; Campbell IG; Chenevix-Trench G
    Breast Cancer Res Treat; 2010 Jan; 119(2):491-6. PubMed ID: 19189213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
    Meyer P; Voigtlaender T; Bartram CR; Klaes R
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA screening.
    Med Lett Drugs Ther; 2007 Nov; 49(1274):93-4. PubMed ID: 18007543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.